Dorenem (Doripenem)

Basic information

Claribaccin is a product that contains the active ingredient clarithromycin, which is a semisynthetic macrolide antibiotic. It is derived from erythromycin by substituting the CN3O hydroxyl group with an (OH) group in the 6th position of the lactone ring. This modification results in clarithromycin being 6-Omethylerythromycin A.

The primary mode of action of clarithromycin is its ability to bind to the 50S ribosomal subunit of bacteria that are sensitive to it. By doing so, it prevents the translocation of activated amino acids, thereby inhibiting the intracellular protein synthesis of these microorganisms. This mechanism ultimately leads to the exertion of clarithromycin's antibacterial properties.

It is important to note that Claribaccin falls within the pharmaceutical industry, specifically in the domain of antimicrobial medications. It is commonly prescribed to treat various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and certain types of sexually transmitted diseases. Its ability to inhibit protein synthesis in bacteria makes it an effective tool in combating the growth and spread of these pathogens.